<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is one of the most frequent <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorders</z:e>, showing striking pleiotropism and clinical variability </plain></SENT>
<SENT sid="1" pm="."><plain>There is <z:hpo ids='HP_0000006'>autosomal dominant inheritance</z:hpo> with complete penetrance but variable expression </plain></SENT>
<SENT sid="2" pm="."><plain>Approximately 25% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> patients have no family history of the syndrome and represent <z:hpo ids='HP_0003745'>sporadic</z:hpo> cases due to new mutations </plain></SENT>
<SENT sid="3" pm="."><plain>This hazardous condition is often associated with premature cardiovascular <z:hpo ids='HP_0011420'>death</z:hpo> unless surveillance and management are optimized </plain></SENT>
<SENT sid="4" pm="."><plain>The fibrillin gene (FBN1) encodes the structure of the connective tissue protein fibrillin </plain></SENT>
<SENT sid="5" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> is caused by mutations in the fibrillin gene, located on chromosome 15 at locus 15q21 </plain></SENT>
<SENT sid="6" pm="."><plain>Fibrillin abnormalities reduce the structural integrity of different body systems, primarily involving the heart valves, blood vessels, lungs, bones, tendons, ligaments, cartilages, eyes, skin, spinal dura and the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> are likely to have too little fibrillin within these structures, resulting in clinically relevant problems </plain></SENT>
<SENT sid="8" pm="."><plain>For example, in the aortic wall, deficient fibrillin may trigger progressive aortic <z:mpath ids='MPATH_474'>ectasia</z:mpath> and may result in <z:hpo ids='HP_0002647'>aortic dissection</z:hpo> </plain></SENT>
</text></document>